Gary Scott Leiserowitz, M.D., M.S.
Obstetrics and Gynecology
Surgery - Robotic
- Chair, Department of Obstetrics and Gynecology
- Professor and Chief, Gynecologic Oncology and Obstetrics and Gynecology - Robotic Surgery
- Fellowship Director, Gynecologic Oncology
- Director, Surgical Services - Department of Obstetrics and Gynecology
- Director, Women�s Cancer Care Program
Gary S. Leiserowitz and his colleagues in the Division of Gynecologic Oncology believe in patient-centered care that is anchored in the most current evidence-based medicine. He works closely with other physicians in medical oncology, radiation oncology and pathology to bring a multidisciplinary focus to each patient’s case.
His extensive surgical experience includes minimally invasive and robotic-assisted procedures for a variety of conditions. As a member and former director of the gynecologic oncology fellowship program at UC Davis, Leiserowitz is also helping train the next generation of specialists in cancers of the female reproductive system.
M.D., University of Iowa College of Medicine, Iowa City IA 1981
M.S., Mayo Graduate School of Medicine, Rochester MN 1993
B.S., University of Iowa, Iowa City IA 1976
Internship: Family Medicine, Ventura County Medical Center, Ventura CA 1981-1982
Obstetrics and Gynecology, UC Davis Medical Center, Sacramento CA 1986-1988
Chief Resident - Obstetrics and Gynecology, UC Davis Medical Center, Sacramento CA 1988-1989
Family Medicine, Ventura County Medical Center, Ventura CA 1982-1984
Gynecologic Oncology, Mayo Clinic, Rochester MN 1990-1993
American Board of Family Medicine,
American Board of Obstetrics and Gynecology, 2002
American Board of Obstetrics and Gynecology, Gynecologic Oncology, 2012
American College of Obstetrics and Gynecology
Council of University Chairs of Obstetrics and Gynecology
Society of Gynecologic Oncologists
Western Association of Gynecologic Oncologists
Honors and Awards
�Top Doctors � Sacramento,� 2016, 2017, 2018, 2019
Dean�s Team Award for Excellence � Clinical Care. Interstitial Brachytherapy for Gynecologic Cancers., 2016
�Best Doctors in America" 2003, 2005, 2013, 2015
2015 Roy M. Pitkin Award; established in 1998 to honor departments of obstetrics and gynecology that promote and demonstrate excellence in research. The winning article is: Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of long-term survivors of epithelial ovarian cancer. Obstet Gynecol 2015;126:491�7., 2016
James F. Nolan Award for best clinical paper. 44th Annual WAGO meeting award: �Comparison of LAVH vs. TAH for Endometrial Cancer for Clinical Outcomes and Survival: A Population-Based Study�, 2014
Sacramento Super Doctors, 2011
Who's Who in Healthcare, 2011
Richard H. Oi, MD OB/GYN Excellence in Teaching Award, Resident Teaching Award, 2009
James F. Nolan Award for best clinical paper, 35th Annual WAGO meeting award, 2006
Select Recent Publications
Chen H, Gotimer K, De Souza C, Tepper CG, Karnezis AN, Leiserowitz GS, Chien J, Smith LH. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol. 2020 Apr 3:S0090-8258(20)30251-1. PMID: 32253045.
Girda E, Huang EC, Leiserowitz GS, Smith LH. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible. Int J Gynecol Cancer. 2017 Oct;27(8):1701-1707. PubMed PMID: 28683005.
Carney RP, Hazari S, Colquhoun M, Tran D, Hwang B, Mulligan MS, Bryers JD, Girda E, Leiserowitz GS, Smith ZJ, Lam KS. Multispectral optical tweezers for biochemical fingerprinting of CD9-positive exosome subpopulations. Anal Chem. 2017 Mar 27. PMID: 28345878.
Leiserowitz GS, Lin JF, Tergas AI, Cliby WA, Bristow RE. Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study. Int J Gynecol Cancer. 2017 Mar 22. PubMed PMID: 28328580.
Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstet Gynecol. 2015 Sep;126(3):491-7.
Kim K, Ruhaak LR, Nguyen UT, Taylor SL, Dimapasoc L, Williams C, Stroble C, Ozcan S, Miyamoto S, Lebrilla CB, Leiserowitz GS. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):611-21.
Ruhaak LR, Taylor SL, Miyamoto S, Kelly K, Leiserowitz GS, Gandara D, Lebrilla CB, Kim K. Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses. Anal Bioanal Chem. 2013 May;405(14):4953-8.
Hua S, Williams CC, Dimapasoc LM, Ro GS, Ozcan S, Miyamoto S, Lebrilla CB, An HJ, Leiserowitz GS. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A. 2013 Mar 1;1279:58-67.
Cress RD, Bauer K, O'Malley CD, Kahn AR, Schymura MJ, Wike JM, Stewart SL, Leiserowitz GS. Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study. Gynecol Oncol. 2011 Apr;121(1):94-9.